Patent · US Active

Opioid antagonists

US8895560B2 · kind B2 · utility

0Cited by
21References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2014
Grant dateNov 25, 2014
Priority date—
Expiry dateMar 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain quinolizidine and octahydropyridopyrazine compounds, pharmaceutical compositions, and methods of their use, inter alia, as opioid receptor antagonists are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.